<p><b>Copyright information:</b></p><p>Taken from "Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages"</p><p>http://www.virologyj.com/content/4/1/126</p><p>Virology Journal 2007;4():126-126.</p><p>Published online 24 Nov 2007</p><p>PMCID:PMC2216014.</p><p></p> The sequences of subtype C chimeras used in this study were analyzed by performing multiple sequence alignment with parental clone HIV-1as a reference and HIV-1and known HIV-1 subtype C envelope regions for comparison. Subtype C chimeras are designated by numbers. Dots indicate a match with the reference sequence whereas substitutions are indicated by the single l...
AbstractWe previously reported that an envelope (Env) glycoprotein immunogen (o-gp140ΔV2SF162) conta...
BACKGROUND: Despite the existence of over 50 subtypes and circulating recombinant forms of HIV-1, su...
Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV...
BACKGROUND:Several subtypes of HIV-1 circulate in infected people worldwide, including subtype B in ...
<p><b>Copyright information:</b></p><p>Taken from "Role of HIV-1 subtype C envelope V3 to V5 regions...
<p><b>Copyright information:</b></p><p>Taken from "Role of HIV-1 subtype C envelope V3 to V5 regions...
We previously reported that an envelope (Env) glycoprotein immunogen (o-gp140DeltaV2SF162) containin...
Abstract Background HIV-1 envelope diversity remains a significant challenge for the development of ...
Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been der...
Le virus de l'immunodéficience humaine (VIH) est responsable du syndrome d'immunodéficience humaine ...
Background Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutr...
Background: The development of a vaccine against HIV/AIDS capable of preventing virus infection has ...
Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been der...
<div><p>Standardized assays to assess vaccine and antiviral drug efficacy are critical for the devel...
Background: Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutr...
AbstractWe previously reported that an envelope (Env) glycoprotein immunogen (o-gp140ΔV2SF162) conta...
BACKGROUND: Despite the existence of over 50 subtypes and circulating recombinant forms of HIV-1, su...
Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV...
BACKGROUND:Several subtypes of HIV-1 circulate in infected people worldwide, including subtype B in ...
<p><b>Copyright information:</b></p><p>Taken from "Role of HIV-1 subtype C envelope V3 to V5 regions...
<p><b>Copyright information:</b></p><p>Taken from "Role of HIV-1 subtype C envelope V3 to V5 regions...
We previously reported that an envelope (Env) glycoprotein immunogen (o-gp140DeltaV2SF162) containin...
Abstract Background HIV-1 envelope diversity remains a significant challenge for the development of ...
Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been der...
Le virus de l'immunodéficience humaine (VIH) est responsable du syndrome d'immunodéficience humaine ...
Background Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutr...
Background: The development of a vaccine against HIV/AIDS capable of preventing virus infection has ...
Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been der...
<div><p>Standardized assays to assess vaccine and antiviral drug efficacy are critical for the devel...
Background: Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutr...
AbstractWe previously reported that an envelope (Env) glycoprotein immunogen (o-gp140ΔV2SF162) conta...
BACKGROUND: Despite the existence of over 50 subtypes and circulating recombinant forms of HIV-1, su...
Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV...